KKR & Co Inc (KKR) has acquired a large stake in Henry Schein (HSIC) and plans to work with the medical- and dental-supply company to boost its operations, The Wall Street Journal reported Wednesday, citing unnamed people familiar with the matter.
The private equity firm plans to reveal an agreement that includes raising its stake in Henry Schein to 12% with an option to buy a further 2.9% in the future, the sources told WSJ.
Henry Schein has also agreed to give the KKR two board seats, with a representative from KKR joining a board committee that has been working on CEO succession planning, according to the report.
KKR and Henry Schein did not immediately respond to MT Newswires' request for comment on the matter.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.